Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion‐positive non–small cell lung cancer
Limin Zhang; Tao Jiang; Xuefei Li; Yan Wang; Chao Zhao; Sha Zhao; Lei Xi; Shijia Zhang; Xiaozhen Liu; Yijun Jia; Hui Yang; Jinpeng Shi; Chunxia Su; Shengxiang Ren; Caicun Zhou
Author Information: Department of Medical Oncology, Shanghai Pulmonary Hospital and Thoracic Cancer Institute
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.